Literature DB >> 24035881

A tissue graft model of DNA damage response in the normal and malignant human prostate.

Taija M Af Hällström1, Hongjuan Zhao2, Junqiang Tian3, Ville Rantanen4, Stephen W Reese2, Rosalie Nolley2, Marikki Laiho5, Donna M Peehl6.   

Abstract

PURPOSE: DNA damage responses are relevant to prostate cancer initiation, progression and treatment. Few models of the normal and malignant human prostate that maintain stromal-epithelial interactions in vivo exist in which to study DNA damage responses. We evaluated the feasibility of maintaining tissue slice grafts at subcutaneous vs subrenal capsular sites in RAG2(-/-)γC(-/-) mice to study the DNA damage responses of normal and malignant glands.
MATERIALS AND METHODS: We compared the take rate and histology of tissue slice grafts from fresh, precision cut surgical specimens that were maintained for 1 to 4 weeks in subcutaneous vs subrenal capsular sites. Induction of γH2AX, p53, ATM and apoptosis was evaluated as a measure of the DNA damage response after irradiation.
RESULTS: The take rate of subcutaneous tissue slice grafts was higher than typically reported but lower than at the subrenal capsular site. Subcutaneous tissue slice grafts frequently showed basal cell hyperplasia, squamous metaplasia and cystic atrophy, and cancer did not survive. In contrast, normal and malignant histology was well maintained in subrenal capsular tissue slice grafts. Regardless of implantation site the induction of γH2AX and ATM occurred in tissue slice graft epithelium 1 hour after irradiation and decreased to basal level by 24 hours, indicating DNA damage recognition and repair. As observed previously in prostatic ex vivo models, p53 was not activated. Notably, tumor but not normal cells responded to irradiation by undergoing apoptosis.
CONCLUSIONS: To our knowledge this is the first study of DNA damage responses in a patient derived prostate tissue graft model. The subrenal capsular site of RAG2(-/-)γC(-/-) mice optimally maintains normal and malignant histology and function, permitting novel studies of DNA damage responses in a physiological context.
Copyright © 2014 American Urological Association Education and Research, Inc. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  DNA damage; H2AFX protein; human; prostate; prostatic neoplasms; transplants

Mesh:

Year:  2013        PMID: 24035881      PMCID: PMC4009951          DOI: 10.1016/j.juro.2013.09.007

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  27 in total

Review 1.  Focus on prostate cancer.

Authors:  William Isaacs; Angelo De Marzo; William G Nelson
Journal:  Cancer Cell       Date:  2002-08       Impact factor: 31.743

2.  Comparison of the zones of the human prostate with the seminal vesicle: morphology, immunohistochemistry, and cell kinetics.

Authors:  István Laczkó; David L Hudson; Alex Freeman; Mark R Feneley; John R Masters
Journal:  Prostate       Date:  2005-02-15       Impact factor: 4.104

3.  Maintaining integrity.

Authors:  Yosef Shiloh; Alan R Lehmann
Journal:  Nat Cell Biol       Date:  2004-10       Impact factor: 28.824

4.  Development and characterization of efficient xenograft models for benign and malignant human prostate tissue.

Authors:  Yuzhuo Wang; Monica P Revelo; Daniel Sudilovsky; Mei Cao; Wilfred G Chen; Lester Goetz; Hui Xue; Marianne Sadar; Scott B Shappell; Gerald R Cunha; Simon W Hayward
Journal:  Prostate       Date:  2005-07-01       Impact factor: 4.104

5.  ATM-mediated response to DNA double strand breaks in human neurons derived from stem cells.

Authors:  Sharon Biton; Michal Gropp; Pavel Itsykson; Yaron Pereg; Leonid Mittelman; Karl Johe; Benjamin Reubinoff; Yosef Shiloh
Journal:  DNA Repair (Amst)       Date:  2006-12-18

6.  Induction of p53 expression in skin by radiotherapy and UV radiation: a randomized study.

Authors:  F Ponten; H Lindman; A Bostrom; B Berne; J Bergh
Journal:  J Natl Cancer Inst       Date:  2001-01-17       Impact factor: 13.506

7.  H2A.X. a histone isoprotein with a conserved C-terminal sequence, is encoded by a novel mRNA with both DNA replication type and polyA 3' processing signals.

Authors:  C Mannironi; W M Bonner; C L Hatch
Journal:  Nucleic Acids Res       Date:  1989-11-25       Impact factor: 16.971

8.  Short-term human prostate primary xenografts: an in vivo model of human prostate cancer vasculature and angiogenesis.

Authors:  Danny R Gray; Wendy J Huss; Jeffrey M Yau; Lori E Durham; Eric S Werdin; William K Funkhouser; Gary J Smith
Journal:  Cancer Res       Date:  2004-03-01       Impact factor: 12.701

9.  A new xenograft model for graft-versus-host disease by intravenous transfer of human peripheral blood mononuclear cells in RAG2-/- gammac-/- double-mutant mice.

Authors:  Rozemarijn S van Rijn; Elles R Simonetti; Anton Hagenbeek; Marieke C H Hogenes; Roel A de Weger; Marijke R Canninga-van Dijk; Kees Weijer; Hergen Spits; Gert Storm; Louis van Bloois; Ger Rijkers; Anton C M Martens; Saskia B Ebeling
Journal:  Blood       Date:  2003-06-05       Impact factor: 22.113

10.  Differentiation-induced radioresistance in muscle cells.

Authors:  Lucia Latella; Jiri Lukas; Cristiano Simone; Pier Lorenzo Puri; Jiri Bartek
Journal:  Mol Cell Biol       Date:  2004-07       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.